BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27799621)

  • 1. Impairment on the lateral mobility induced by structural changes underlies the functional deficiency of the lupus-associated polymorphism FcγRIIB-T232.
    Xu L; Xia M; Guo J; Sun X; Li H; Xu C; Gu X; Zhang H; Yi J; Fang Y; Xie H; Wang J; Shen Z; Xue B; Sun Y; Meckel T; Chen YH; Hu Z; Li Z; Xu C; Gong H; Liu W
    J Exp Med; 2016 Nov; 213(12):2707-2727. PubMed ID: 27799621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defunctioning polymorphism in the immunoglobulin G inhibitory receptor (FcγRIIB-T/T232) does not impact on kidney transplant or recipient survival.
    Clatworthy MR; Matthews RJ; Doehler B; Willcocks LC; Opelz G; Smith KGC
    Transplantation; 2014 Aug; 98(3):285-291. PubMed ID: 25022320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FcgammaRIIB Ile232Thr transmembrane polymorphism associated with human systemic lupus erythematosus decreases affinity to lipid rafts and attenuates inhibitory effects on B cell receptor signaling.
    Kono H; Kyogoku C; Suzuki T; Tsuchiya N; Honda H; Yamamoto K; Tokunaga K; Honda Z
    Hum Mol Genet; 2005 Oct; 14(19):2881-92. PubMed ID: 16115811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FcγRIIb inhibits immune complex-induced VEGF-A production and intranodal lymphangiogenesis.
    Clatworthy MR; Harford SK; Mathews RJ; Smith KG
    Proc Natl Acad Sci U S A; 2014 Dec; 111(50):17971-6. PubMed ID: 25475856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FcγRIIB-I232T polymorphic change allosterically suppresses ligand binding.
    Hu W; Zhang Y; Sun X; Zhang T; Xu L; Xie H; Li Z; Liu W; Lou J; Chen W
    Elife; 2019 Jul; 8():. PubMed ID: 31343409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel polymorphism in the Fcgamma receptor IIB (CD32B) transmembrane region alters receptor signaling.
    Li X; Wu J; Carter RH; Edberg JC; Su K; Cooper GS; Kimberly RP
    Arthritis Rheum; 2003 Nov; 48(11):3242-52. PubMed ID: 14613290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of FcγRIIB by resveratrol via NF-κB activation reduces B-cell numbers and ameliorates lupus.
    Jhou JP; Chen SJ; Huang HY; Lin WW; Huang DY; Tzeng SJ
    Exp Mol Med; 2017 Sep; 49(9):e381. PubMed ID: 28960214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transmembrane domain dependent inhibitory function of FcγRIIB.
    Wang J; Li Z; Xu L; Yang H; Liu W
    Protein Cell; 2018 Dec; 9(12):1004-1012. PubMed ID: 29497990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Through an ITIM-independent mechanism the FcγRIIB blocks B cell activation by disrupting the colocalized microclustering of the B cell receptor and CD19.
    Xu L; Li G; Wang J; Fan Y; Wan Z; Zhang S; Shaheen S; Li J; Wang L; Yue C; Zhao Y; Wang F; Brzostowski J; Chen YH; Zheng W; Liu W
    J Immunol; 2014 Jun; 192(11):5179-91. PubMed ID: 24790152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FcγRIIB-Independent Mechanisms Controlling Membrane Localization of the Inhibitory Phosphatase SHIP in Human B Cells.
    Pauls SD; Ray A; Hou S; Vaughan AT; Cragg MS; Marshall AJ
    J Immunol; 2016 Sep; 197(5):1587-96. PubMed ID: 27456487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of function of a lupus-associated FcgammaRIIb polymorphism through exclusion from lipid rafts.
    Floto RA; Clatworthy MR; Heilbronn KR; Rosner DR; MacAry PA; Rankin A; Lehner PJ; Ouwehand WH; Allen JM; Watkins NA; Smith KG
    Nat Med; 2005 Oct; 11(10):1056-8. PubMed ID: 16170323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fcgamma receptor IIB and IIIB polymorphisms and susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis.
    Lee YH; Ji JD; Song GG
    Lupus; 2009 Jul; 18(8):727-34. PubMed ID: 19502269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FcgammaRIIB, FcgammaRIIIB, and systemic lupus erythematosus.
    Niederer HA; Clatworthy MR; Willcocks LC; Smith KG
    Ann N Y Acad Sci; 2010 Jan; 1183():69-88. PubMed ID: 20146709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased transcription of the human FCGR2B gene mediated by the -343 G/C promoter polymorphism and association with systemic lupus erythematosus.
    Blank MC; Stefanescu RN; Masuda E; Marti F; King PD; Redecha PB; Wurzburger RJ; Peterson MG; Tanaka S; Pricop L
    Hum Genet; 2005 Jul; 117(2-3):220-7. PubMed ID: 15895258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of the immune response in pristane-induced lupus by expression of activation and inhibitory Fc receptors.
    Clynes R; Calvani N; Croker BP; Richards HB
    Clin Exp Immunol; 2005 Aug; 141(2):230-7. PubMed ID: 15996187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of B cell receptor-mediated activation of primary human B cells by coengagement of CD19 and FcgammaRIIb with Fc-engineered antibodies.
    Chu SY; Vostiar I; Karki S; Moore GL; Lazar GA; Pong E; Joyce PF; Szymkowski DE; Desjarlais JR
    Mol Immunol; 2008 Sep; 45(15):3926-33. PubMed ID: 18691763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-mediated coengagement of FcγRIIb and B cell receptor complex suppresses humoral immunity in systemic lupus erythematosus.
    Horton HM; Chu SY; Ortiz EC; Pong E; Cemerski S; Leung IW; Jacob N; Zalevsky J; Desjarlais JR; Stohl W; Szymkowski DE
    J Immunol; 2011 Apr; 186(7):4223-33. PubMed ID: 21357255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression profile of FcgammaRIIb on leukocytes and its dysregulation in systemic lupus erythematosus.
    Su K; Yang H; Li X; Li X; Gibson AW; Cafardi JM; Zhou T; Edberg JC; Kimberly RP
    J Immunol; 2007 Mar; 178(5):3272-80. PubMed ID: 17312177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allelic-dependent expression of an activating Fc receptor on B cells enhances humoral immune responses.
    Li X; Wu J; Ptacek T; Redden DT; Brown EE; Alarcón GS; Ramsey-Goldman R; Petri MA; Reveille JD; Kaslow RA; Kimberly RP; Edberg JC
    Sci Transl Med; 2013 Dec; 5(216):216ra175. PubMed ID: 24353158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of rheumatoid arthritis B cells by XmAb5871, an anti-CD19 antibody that coengages B cell antigen receptor complex and Fcγ receptor IIb inhibitory receptor.
    Chu SY; Yeter K; Kotha R; Pong E; Miranda Y; Phung S; Chen H; Lee SH; Leung I; Bonzon C; Desjarlais JR; Stohl W; Szymkowski DE
    Arthritis Rheumatol; 2014 May; 66(5):1153-64. PubMed ID: 24782179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.